top of page

Research Professor Georgios S. Stamatakos, father of in silico medicine,  specializes in the analysis and simulation of biological systems and their interaction with electromagnetic radiation at the Institute of Communication and Computer Systems (ICCS), School of Electrical and Computer Engineering (ECE), National Technical University of Athens (NTUA). He has been a Visiting Professor of Medical School, University of Saarland (Medizinische Fakultät, Universität des Saarlandes), Germany and ECE, NTUA. He is the Founder and the Director of In Silico Oncology and In Silico Medicine Group, ICCS-ECE-NTUA ( His pioneering work on the founding, the shaping and the advancement of in silico medicine is summarized i.a. in the following articles and the ones referred to therein: and .

Ηe has published more than 190 articles in international peer reviewed journals, conference proceedings and scientific books (books and book chapters).

Ηe has taught several courses at both undergraduate and postgraduate levels at ECE and the School of Applied Mathematical and Physical Sciences of NTUA as well as at the Hellenic Army's Postgraduate School of Telecommunications (STIAD). Τhe courses he has taught include Electromagnetic Fields and Microwaves, Optoelectronics Laboratory Courses, Laser Technology and Applications Laboratory Courses, Physics Laboratory Courses, Multiscale Cancer Modeling and In Silico Medicine, Research Methodology and Computational Modeling in Health and Disease.

He formulated and proposed the postgraduate course (705-ECE-NTUA) entitled: "Multiscale Cancer Modeling and In Silico Medicine", which he has been teaching at ECE, NTUA since 2014. The latter has proved the first postgraduate course dedicated to the emergent domain of in silico medicine on a global scale ( The course description is available at

G. Stamatakos has served as advisor for many diploma and doctoral theses in ECE.

He holds an MSc degree in electrical engineering from NTUA, an MSc degree in bioengineering from the University of Strathclyde, Glasgow, UK, and a Ph.D. degree in physics (biophysics) from NTUA. He has also been a postdoctoral fellow in medical technology at ICCS-NTUA as a National Grant Foundation (IKY) grant recipient.

He proposed the concept and the system of the "Oncosimulator" (video available at ). He pioneered the development of the Oncosimulator of the EC and Japan co-funded ACGT Integrated Project, a "world first" ( He also led the development of the Oncosimulators of several other competitive EC funded and international projects, mostly centered around the initiative of the Virtual Physiological Human (VPH) initiative (ContraCancrum, TUMOR, p-medicine, DR THERAPAT, MyHealthAvatar etc.). A major clinical collaborator in his research endeavours has been Norbert Graf, Professsor of Paediatric Oncology and Hematology, Medical School, University of Saarland, Germany.

G. Stamatakos was the scientific and the overall coordinator as well as the leader of the fundamental science part of the large scale EU-US integrating research project CHIC on in silico oncology ( The latter was funded by the European Commission with a grant of 10,582,000 €. Seventeen leading academic, research, clinical and industrial partner organizations across Europe and US participated in CHIC. The CHIC project underwent its final review on 23 and 24 May 2017 and was assessed as "excellent" by the Board of five External Reviewers appointed by the European Commission. A press release article on the "great achievements" of the CHIC project is available on the official website of the European Commission at  A list of the major achievements of CHIC is available at A related news article published on the SECE website is available on

He has led the predictive computer models action of the EU funded H2020 project BOUNCE entitled: “Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back.” (Project ID: 777167, .) ΒOUNCE was primarily based on an extensive clinical application of Artificial Intelligence (AI) strategies and techniques.

He proposed the term and the concept of "In Silico Oncology" denoting a new clinical trial driven scientific and technological discipline, primarily based on multiscale mechanistic biomodelling and in silico experimentation (i.e. experimentation on the computer). In Silico Oncology has also proved a precursor of the generic in silico medicine (

From 1st July 2019 till 15th September 2019 he worked at the Medical School, University of Saarland, Germany, as an invited Visiting Professor, focusing on the clinical validation of the pioneering multiscale Oncosimulator of paediatric nephroblastoma which was designed and developed at ICCS-SECE-NTUA under his leadership and the clinical support of Prof. N. Graf, Medical School, University of Saarland (

He (co-) initiated and (co-) organized a number of international research workshops, including the IARWISOCI series on in silico oncology and cancer investigation ( - open access to the Proceedings) and the First Transatlantic (EU-US) Workshop on Multiscale Cancer Modeling (ICT 2008, Brussels 2008, A video of the opening talk of the latter delivered by G. Stamatakos is available at the ecancer oncology portal: . He was an organizer and invited speaker at the Virtual Physiological Human (VPH2018) Conference dedicated to in silico medicine. This conference took place in Zaragoza, Spain on 5-6 Sept. 2018.

He was co-editor, contributor and reviewer of the transatlantic multi-author textbook entitled "Multiscale Cancer Modeling" published by CRC Press in 2010/2011 ( and The US co-editor of the book was Thomas Deisboeck, MD, Associate Professor, Massachusetts General Hospital and Harvard Medical School. He was also co-editor of the Proceedings of the six international IARWISOCI conferences on in silico oncology and cancer investigation.

He is an expert of the European Research Council (ERC) established by the European Commission. He has been elected one of the three members of the Board of Trustees of the international “Virtual Physiological Human Institute” (VPHi) ( ) and Co-Chair of the Cancer and In Silico Oncology Task Force, Avicenna Alliance for Predictive Medicine ( He is an Associate Editor of Frontiers in Physiology "Computational Physiology and Medicine" section. ). He is also a member of the Editorial Board of Cancer Informatics. He serves as a referee for numerous scientific peer reviewed journals including Nature Reviews Clinical Oncology and Nature Scientific Reports. G. S.Stamatakos is a member of IEEE and the Technical Chamber of Greece.

The address of G. Stamatakos' webpage on the international researchers' database ORCID is

Courses currently taught 

705 Multiscale Cancer Modelling and In Silico Medicine (ECE Program of Doctoral Studies)

bio1004 Research Methodology

bio1006 Computational Modeling and Simulation for Medicine (Coordinator of the course)

Research Interests

in silico medicine (computational medicine), in silico oncology, digital twins (virtual twins). multiscale cancer modeling, mechanistic modeling, biomedical applications of Artificial Intelligence with special emphasis in oncology, in silico psychooncology, in silico oncological psychiatry, systems medicine, precision medicine, the Virtual Physiological Human (VPH) initiative, systems biology, bioinformatics, biomedical engineering, bioengineering, bioelectromagnetics, biooptics, computational electromagnetics, software engineering, applied mathematics


 Publications Link


bottom of page